Models

New drugs for neurological disease have been noticeably scarce over the last 20 years. Current market offerings are either relatively ineffective or result in unacceptable side effects, resulting in a dramatic unmet need for new treatment options. Moreover, current products only treat symptoms and do not address disease progression. Much of the industry’s inability to produce new drug candidates has been primarily due to the lack of relevant animal disease models. CNS|CRO provides animal models that are progressive and slow developing which translates into more accurate replication of human disease progression. The ability to evaluate candidates at more stages of the disease’s development make our models ideal for identification of early stage treatments. CNS|CRO’s proprietary models demonstrate behavioural characteristics and pathologies associated with human disease progression.

In addition to proprietary offerings, CNS|CRO also offers traditional animal models, as well as histology services and specialty platforms.

CNS|CRO Current Offerings Sheet
CNS|CRO Current Offerings – Information Sheet

Please contact info@cnscro.com for further details.